Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedLocations changed: 180 → 177 (4 deletions, 1 addition) with a new Wenzhou entry and new affiliation; metadata updated to revision v3.0.2 in September 2025.SummaryDifference4%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility locations across various countries, while also removing several previously listed locations. Notably, the names of cities and countries have been retained or replaced, ensuring the core content remains relevant.SummaryDifference19%
- Check24 days agoChange DetectedThe page has updated the number of study locations from 181 to 180 and has added specific dates related to the study, including a new completion date of August 19, 2025.SummaryDifference1.0%
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.